Effect of Hip-focused Neuromuscular Activation Exercise on Foot Posture and Neuromuscular Control

Overview

This study planned to investigate the effect of hip-focused neuromuscular activation exercise on foot posture and neuromuscular control in symptomatic and asymptomatic participants. We will follow a cross-over study design to compare the effect of hip focused neuromuscular activation exercise or a sham exercise on foot posture and lower extremity biomechanics. Foot posture will be assessed by Navicular Drop Test (NDT), and lower extremity neuromuscular control will be assessed with Star Excursion Y-Balance Test (SEBT-Y) and Frontal Plane Projection Angle (FPPA) during single leg squat before and after the experiments. The results of this study may provide scientific knowledge for a kinetic chain approach during functional foot rehabilitation.

Full Title of Study: “A Cross-over Study to Investigate the Effect of Hip-focused Neuromuscular Activation Exercise on Foot Posture and Neuromuscular Control”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Outcomes Assessor)
  • Study Primary Completion Date: June 12, 2019

Interventions

  • Other: Exercise
    • Hip focused Neuromuscular Activation Exercise

Arms, Groups and Cohorts

  • Experimental: Neuromuscular Exercise
    • Neuromuscular Exercise
  • No Intervention: Control
    • No intervention
  • Sham Comparator: Sham Exercise
    • Sham Exercise

Clinical Trial Outcome Measures

Primary Measures

  • Navicular Drop Test
    • Time Frame: 1 year
    • Navicular Drop Test

Secondary Measures

  • Star Excursion Y-Balance Test
    • Time Frame: 1 year
    • Star Excursion Y-Balance Test
  • Frontal Plane Projection Angle
    • Time Frame: 1 year
    • Frontal Plane Projection Angle

Participating in This Clinical Trial

Inclusion Criteria

  • To be included, participants should be between the ages of 18 and 45 years. Exclusion Criteria:

  • Participants will be excluded from this study if they have a history of lower body trauma or surgery, or positive trendelenburg sign and slump test.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Hacettepe University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Elif Turgut, Associate Proffessor – Hacettepe University
  • Overall Official(s)
    • Elif Turgut, PhD, Principal Investigator, Hacettepe University
  • Overall Contact(s)
    • Elif Turgut, PhD, 00903123051576, elifcamci@hacettepe.edu.tr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.